Phlebolymphedema: Health and Economic Benefits of Flexitouch Therapy

This insurance-claims analysis, published in the Journal of Vascular Surgery, reveals the impact of Flexitouch therapy on healthcare costs in venous-related  lymphedema (phlebolymphedema).

Flexitouch therapy plus conservative treatment reduced healthcare costs by:

• 69% compared with conservative therapy alone.
• 85% compared with simple pneumatic compression devices (SPCDs).
• 53% compared with other advanced pneumatic compression devices (APCDs).